Be-Sheng Kuo(郭必盛), Ph.D.
Board Director

Be-Sheng Kuo is currently the senior director of pre-clinical development at AbGenomics Corp. in Taiwan. He has 17 years of experience in pharmaceutical research and development, specializing in preclinical development of both therapeutic and small molecule drugs. He has authored more than 30 scientific publications. Before returning to Taiwan, Dr. Kuo held positions at various U.S. pharmaceutical companies, including Biogen Idec, Pfizer and Aventis. Dr. Kuo received his B.S. in Pharmacy from Taipei Medical University in Taiwan, and his Ph.D. in biopharmaceutics from the University of Cincinnati, Ohio.